UPDATE 2-Sanofi gets FDA warning over Uroxatral promotion

NEW YORK, Oct 27 (Reuters) - The U.S. Food and Drug Administration has sent a warning letter to Sanofi-Aventis accusing the French drugmaker of distributing misleading promotional material on its Uroxatral treatment for urinary... [read full story]                    

powered by
Add Comment
There are also 1 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies